Singapore Retail Investors

UBS (Lux) Equity SICAV - All China (USD) (SGD) P-acc
Last update
23.02.2021
ISIN: LU1993786604
General information
Name of fund |
UBS (Lux) Equity SICAV - All China (USD) |
---|---|
Share class |
UBS (Lux) Equity SICAV - All China (USD) (SGD) P-acc |
ISIN |
LU1993786604 |
Fund domicile |
LU |
Fund type |
open-end |
Benchmark1) |
MSCI China All-Share (net div. reinv.) in SGD |
Launch date |
23.05.2019 |
Currency of share class |
SGD |
Accounting year end |
31 May |
1) Reference index change on 27.11.2019 - old: MSCI All China index, new: MSCI China All Share index
Fund description
- Actively managed equity fund based on an equity portfolio investing in selected Chinese companies.
- The manager is given great flexibility to take focused views on the most attractive stocks and exploit the best opportunities, unconstrained by the reference index.
- Diversified across sectors offering broad coverage of the onshore and offshore Chinese equity market.
- The exchange rate risk between USD and SGD is not hedged.
Current fund data and tax figures
NAV Date |
23 Feb 2021 |
---|---|
Official NAV per share |
165.21 |
Total fund assets (USD m) |
5,219.44 |
Key benefits
- Easy access to investment opportunities provided by a rapidly growing Chinese economy. Investors gain access to all classes of shares, providing exposure to onshore and offshore China equities: A, B and H shares, Red chips, P chips and ADRs.
- Due to the significant deviation from the reference index, the fund offers the potential to outperform the reference index.
- Investors benefit from UBS being one of the few asset managers with a truly global investment platform.
- The experienced portfolio management team can leverage local investment expertise in the Chinese market via our joint venture UBS SDIC in China.
Performance chart (in fund currency)
Reference index change on 27.11.2019 - old: MSCI All China index, new: MSCI China All Share index
These figures refer to the past. Past performance is not a reliable indicator of future results. Fund performance is net of fees. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units.
Fees
Management fee p.a. |
1.72% |
---|---|
Total expense ratio (TER) p.a.1) |
2.25% |
Singapore Sales Charges (in %) |
none |
1) as at 31.05.2020
Risks
UBS Emerging Market Funds invest in equities and may therefore be subject to high fluctuations in value. For this reason, an investment horizon of at least five years and corresponding risk tolerance and capacity are required. As these UBS Funds pursue an active management style, each Fund's performance can deviate from that of its reference index. Investors should also be aware of the political and social challenges that emerging markets face. All investments are subject to market fluctuations. Every Fund has specific risks, which can significantly increase under unusual market conditions.
The official NAV reflects the price in which investors can buy or sell units in the Fund. Please note that the adjusted NAV is not to be relied on for buying or selling of units in the Fund.